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Priorities in Global 
Assistance for Health, 
AIDS, and Population 
LANDIS MACKELLAR 
IN RECENT YEARS, the possibility of a deadly influenza pandemic, the episode 
of severe acute respiratory syndrome (SARS), concerns over bioterrorism, 
the HIV I AIDS epidemic, and no doubt other events have increased the im-
portance with which global public health is viewed. Even without an "event," 
though, health has a strong claim on our attention, for humanitarian rea-
sons if none other. The World Bank's 1993 World Development Report, a flag-
ship document in the field of health and development, identified a mini-
mum care package that would cost a mere US$12 per capita (in 1990 terms) 
to deliver. The World Health Organization (WHO) estimates that the cost of 
an essential health care package in low-income countries is $12 per capita, 
and in middle-income countries $22 per capita. The comparison between 
the misery caused by poor health in the developing world and the appar-
ently trivial sums required to improve it could not be more striking. 
But is the global community willing to act? The international assis-
tance required to finance adequate levels of health in poor countries was 
estimated by the WHO Commission on Macroeconomics and Health (2001) 
to be $27 billion in 2007: $22 billion for in-country programs, $3 billion for 
research and development targeted at diseases of the poor, and $2 billion in 
classic global public goods such as collection and analysis of epidemiologi-
cal data and surveillance of infectious disease. This sum may be compared 
to actual spending of only about $6 billion per year in 2001. The United 
Nations High Level Panel on Financing for Development, the so-called Zedillo 
Commission, estimated that an extra US$7-10 billion per year in resources 
is required at a minimum to fight communicable diseases alone (United Na-
tions 200 I). 
This enormous gap between needs and current spending suggests that, 
however innovative the funding strategies devised, Zedillo- and WHO-size 
goals are unlikely to be met in anything approaching their entirety. When 
needs vastly outstrip resources, priority setting is crucial. Aggregate trends 
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in official development assistance for health, AIDS, and population have 
been documented (OECD 2001: 139-150; Development Assistance Com-
mittee-UNAIDS 2004 for HIV/AIDS), and the question of how disease pri-
orities ought to be set has received a great deal of attention. Apart from anal-
ysis by Shiffman (2004) on infectious disease, however, little work has been 
done on how they actually are set. 
This article consists of three parts. The first examines international as-
sistance for health, AIDS, and population for two years, 1993 and 2003. 
This period is roughly framed by two landmark events in international health 
policy: publication in 1993 of the aforementioned World Development Report, 
subtitled Investing in Health; and publication at the end of 2001 of the Re-
port of the WHO Commission on Macroeconomics and Health. During this 
decade, health emerged as a key strategic sector in development, and links 
between health and poverty were increasingly recognized. 
The second part, building on the approach that Shiffman has applied 
to infectious disease, compares development assistance for health, AIDS, 
and population in various intervention categories to the burden of disease 
in the corresponding disease categories. The question is how closely devel-
opment assistance allocations match the burden of disease and, where they 
do not, what the explanation might be. 
The third part summarizes an ad hoc but innovative attempt to assess 
stated health priorities in poor countries and the extent to which patterns 
of official development assistance conform to them. While concerns have 
long been expressed that international assistance may not reflect priorities 
in recipient countries (Maizels and Nissanke 1984), this concern has lately 
been heightened as the global public good perspective on health is increas-
ingly used to justify support for spending ( Sagasti and Bezanson 2001; 
Sandler and Arce 2001). It also reflects the conviction, expressed, for ex-
ample, at the March 2005 High Level Forum on Aid Effectiveness in Paris, 
that aid is effective only if it is aligned with country priorities. 
Trends in aggregate development assistance and 
in assistance for health and population 
In view of the gap between resources and needs, a range of innovative ap-
proaches to health financing has been proposed (Atkinson 2003; Reisen 
2004; Stansfield et al. 2001 ). Innovative public-private partnerships are un-
derway in the form of the Global Fund to Fight AIDS, Tuberculosis and 
Malaria; the International AIDS Vaccine Initiative; the US President's Emer-
gency Program for AIDS Relief; the Global Alliance for Vaccines and Immu-
nization; Stop TB; and Roll Back Malaria. However, the bulk of resources 
for these and other initiatives still comes from the traditional source: do-
nor-country governments as represented in the Development Assistance 
Committee and, to a lesser extent, multilateral institutions such as the World 
LANDIS MA CKELLAR 295 
Bank. 1 The primary vehicle for in-country projects remains official devel-
opment assistance; therefore, trends in such assistance should be a reason-
able measure of global priorities. 
Aggregate development assistance 
The standard source for data on official development assistance is the Creditor 
Reporter System database maintained by the Development Assistance Com-
mittee. The data employed in this article were compiled by aggregating, for 
1993 and 2003 (the most recent year available), the finest-grained infor-
mation available in the database.2 In an effort to be comprehensive, I in-
clude all donors, all recipients, and all types of assistance, including loans 
(fairly few and far between in assistance for health, AIDS, and population). 
The limitations of the Creditor Reporter System database are well 
known. The Organization for Economic Co-operation and Development has 
estimated that it is only about 75 to 80 percent complete for the 1990s (OECD 
2001: 140). Data are for commitments, not actual disbursements, which 
may be significantly lower. Other problems include the fact that classifica-
tion in the database is all-or-nothing: for example, a reproductive health 
and family planning project that includes a substantial HIV I AIDS compo-
nent will not appear in the HIV/AIDS category. The database does not cover 
private foundations and nongovernmental organizations (NGOs) and is in-
complete for UN agencies and the European Commission through its Euro-
pean Development Fund. Nevertheless, the Creditor Reporting System data 
continue to be widely used to identify major trends in and characteristics of 
development assistance. 
In the Development Assistance Committee classification system, health 
activities fall under the category "Social infrastructure and services." They 
are further subdivided into "General health" (health policy and administra-
tive management, medical education/training, medical research, and medi-
cal services) and "Basic health" (basic health care, basic health infrastruc-
ture, basic nutrition, infectious disease control, health education, and health 
personnel development). Population activities encompass population policy 
and administrative management, reproductive health care, family planning, 
sexually transmitted disease (STD) control including HIV I AIDS, and per-
sonnel development for population and reproductive health. In fact, HIV I 
AIDS accounts for almost all assistance for STD control. 
Areas of development assistance not directly related to health, AIDS, 
and population are other social infrastructure and services (aid to the edu-
cation sector, water and sanitation projects, and projects aimed at encour-
aging good governance and the development of civil society), economic in-
frastructure (banking, transport, etc.), sector aid (agriculture, industry, etc.), 
commodity and general programmatic assistance (chiefly nonemergency food 
aid, structural adjustment funds, and general budget/balance-of-payments 
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support), multisector assistance (women in development, environment, and 
rural development), and actions related to debt (debt forgiveness, resched-
uling, etc.). Some of these, such as water and sanitation and nutrition, clearly 
have health benefits; indeed, one could argue that any assistance that ac-
celerates development is bound to benefit health. In this article, however, I 
consider only interventions explicitly assigned to the health category. 
Development assistance for health, AIDS, and 
population, 1993 and 2003 
As shown in Table 1, official development assistance for health, AIDS, and 
population is estimated to have more than doubled, from $3, 107 million in 
1993 to $6, 719 million in 2003 (these and all other figures given here are 
in 2002 prices). The implied growth rate of 8.0 percent per annum con-
firms the rapid expansion in this sector. Total development assistance grew 
more slowly, by 5.9 percent per annum over the period, so the share de -
voted to health, AIDS, and population increased from 5.5 percent to 6.7 
percent of total development assistance. While the share of assistance de-
voted to health is only one measure of priority, this is evidence that in-
creasing attention to the health sector in development is being backed up 
with development assistance resources. Many of these resources, however, 
were devoted to the unforeseen HIV I AIDS crisis. In 1993, HIV I AIDS repre-
sented an insignificant 0.1 percent of total development assistance; in 2003, 
it represented 1.8 percent-an increase at a rate of 36.7 percent per an-
num. Health and population minus HIV/AIDS actually lost share in total 
TABLE 1 Official development assistance for health, AIDS, and 
population, US$ million (2002 prices) 
Health, AIDS, and population 
AIDS 
Health and population 
Total development assistance 
Health, AIDS, and population share in 
total development assistance (percent) 
AIDS share in total development 
assistance (percent) 
Health and population share in total 
development assistance (percent) 
SOURCE: Creditor Reporting System. 
1993 
3,107 
77 
3,030 
56,451 
5.5 
0 .1 
5.4 
2003 
6,719 
1,754 
4,965 
99,892 
6.7 
1.8 
5.0 
Growth rate 
(percent per 
annum) 
8 .0 
36.7 
5.1 
5.9 
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development assistance over the decade, from 5.4 percent in 1993 to 5.0 
percent in 2003. 
Table 2 focuses on those health, AIDS, and population intervention 
subsectors most broadly identified as "pro-poor." This list consists of "Basic 
health" as defined by the Development Assistance Committee, plus repro-
ductive health and family planning and STDs including HIV/AIDS. 
Taken together, the pro-poor subsectors experienced an increase in 
share between 1993 and 2003, from 3.3 percent to 4.6 percent of total offi-
cial development assistance and from 59.7 percent to 68.l percent of devel-
opment assistance for health, AIDS, and population. Once the category HIV I 
AIDS is removed, however, the share of the remaining pro-poor subsectors 
declined from 3.1 percent to 2.8 percent of total development assistance 
and from 57.2 percent to 42.0 percent of assistance for health, AIDS, and 
population. 3 Removing HIV I AIDS from the calculations reveals both that 
health lost share of total development assistance and that assistance for 
health, AIDS, and population aid became less pro-poor over the decade . 
The only one of the non-HIV/AIDS subsectors in Table 2 that experi-
enced an increase in share was infectious disease control, rising from 0.2 
percent to 0. 7 percent of total official development assistance and from 3.5 
percent to 10.2 percent of assistance for health, AIDS, and population. Be-
cause infectious disease control is a classic public good, this increase in share 
may be evidence of the growing importance of the global public good per-
TABLE 2 Health, AIDS, and population intervention subsector shares in 
official development assistance, 1993 and 2003 
Intervention subsector 
Basic health care and infrastructure 
Health education and personnel 
development 
Basic nutrition 
Infectious disease control (excl . HIV/AIDS) 
Reproductive health and family planning 
Total, pro-poor subsectors excl. STDS 
and HIV/AIDS 
STDs incl. HIV/AlDS 
Grand total, pro-poor health, AIDS, and 
population subsectors 
SOURCE: Creditor Reporting System. 
Share of intervention subsector in 
All development 
assistance 
1993 2003 
0.8 0.8 
0.3 0.1 
0 .6 0.2 
0.2 0.7 
1.2 1.1 
3.1 2.8 
0.1 1.8 
3.3 4.6 
Health, AIDS, 
and population 
development 
assistance 
1993 2003 
14. l 12.2 
6.2 0.8 
10.9 2.8 
3.5 10.2 
22.5 16.0 
57.2 42.0 
2.5 26.l 
59.7 68. l 
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spective on health. However, many other factors, such as growing realiza-
tion of links between infectious disease and development and increased ap-
preciation of cost-effective responses such as anti-mosquito bed nets, could 
also be explanations. 
While disaggregated data are not shown in Table 2, similar observa-
tions can be made for countries classified as "least-income" by the Develop-
ment Assistance Committee. In these countries, development assistance for 
health, AIDS, and population increased from 5.9 percent to 7.2 percent of 
total assistance; but once HIV/AIDS is removed, health and population ex-
perienced a decline in share, from 5.6 percent to 4 .6 percent. Development 
assistance in the pro-poor, non-HIV/AIDS subsectors declined from 3.2 per-
cent to 2.4 percent of total development assistance and from 54.8 percent 
to 36.3 percent of assistance for health, AIDS, and population. The share of 
assistance for HIV I AIDS increased from 0.2 percent to 2.6 percent of total 
development assistance and from 4.3 percent to 36.3 percent of assistance 
for health, AIDS, and population. Thus, while the pro-poor subsectors taken 
as a whole experienced an increase from 3.2 percent to 5.0 percent of total 
official development assistance and from 54.8 percent to 70.0 percent of 
health, AIDS, and population assistance, it was HIV I AIDS that accounted 
for this increase. Infectious disease control again stands out, however, as a 
subsector that gained share, from 0.2 percent to 0.4 percent of total devel-
opment assistance and from 2.7 percent to 5.0 percent of assistance for 
health, AIDS, and population. 
To summarize, then, over a decade during which health became a major 
component of development strategy and links between health and poverty 
were increasingly recognized, health and population apart from HIV I AIDS 
actually lost share in total official development assistance. Even more strik-
ing, with the exception of HIV/AIDS, subsectors of health, AIDS, and popu-
lation generally considered pro-poor also lost weight. These trends are ob-
served not only for low- and middle-income countries as a whole, but also 
for the subset of least-income countries. 
Health and population assistance and 
the burden of disease 
Priority setting is particularly crucial when available resources fall far short of 
needs. A great deal of normative work has been devoted to how interna-
tional disease control priorities should be set. The flagship project in this area, 
the WHO-World Bank-US National Institutes of Health Disease Control Pri-
orities Project, emphasizes the burden of disease as measured in disability-
adjusted life years. The Global Forum for Health Research (2004) has pro-
posed a framework in which health research and development priorities should 
be set according to reduction in the burden of disease per dollar spent, the 
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determinants of the burden of disease, impact on equity, the scientific prob-
ability of success, feasibility, and contribution to capacity building. 
Much less attention has been given to the equally important question 
of how global disease priorities are actually set. An exception to this is ongo-
ing work by Shiffman (2004), who examines donor priorities in the area of 
infectious disease and concludes that considerations include not only the bur-
den of disease, but also the speed of spread, the ability of poor countries to 
cope on their own, the existence of cost-effective interventions, the charac-
teristics of the victims of disease, the prevalence and risk of infection in do-
nor countries, and other political and economic factors. This section extends 
the work of Shiffman to cover all forms of disease, not just infectious disease. 
Following him, I compare data on health interventions from the Creditor Re-
porter System (CRS) database with WHO data on the burden of disease. I 
conclude that the burden of disease as conventionally measured can explain 
only part of health priorities as revealed by patterns of assistance. 
The burden of disease has many dimensions: years of life lost due to 
premature death, physical suffering due to pain and disability, economic 
opportunity costs, social stigma, and so on. No single measure can capture 
all these aspects; however, health policymakers have generally accepted dis-
ability-adjusted life years (DALYs) lost to given disease categories as the 
best comprehensive measure of the burden of disease. One DALY repre-
sents a single lost year of healthy life, and the sum of DALYs lost to all 
causes can be interpreted as the gap between the actual health situation 
and an ideal world in which everyone lives disease- and disability-free to 
an advanced age (age 80 for men and 82.5 for women, according to the 
convention used by WHO). DALYs lost to a given disease category divided 
by total DALYs lost is a measure of the importance of that disease category 
relative to all diseases combined.4 
Column 1 in Table 3 contains the estimated burden of disease (in 
DALYs) by major disease category for the year 2001. Four of these disease 
categories are directly comparable to development assistance intervention 
subsectors in the database of the Creditor Reporter System. These disease 
categories are 
-Infectious diseases excluding HIV/AIDS and other STDs. This cat-
egory, accounting for 23.6 percent of the total burden of disease in 2001, 
corresponds to "infectious disease control" in the CRS database. 
-STDs including HIV I AIDS, accounting for 5.8 percent of the total bur-
den of disease, is directly comparable to the same category in the CRS data-
base. Readers are sometimes surprised by the modest share of DAL Ys ac-
counted for by HIV I AIDS, but this is the result of the very large number of 
life years lost to other conditions such as malaria and respiratory infections. 
-Maternal health and perinatal conditions; this category corresponds 
to "reproductive health care" and, because of the important role of child 
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TABLE 3 Burden of disease in low- and middle-income countries and 
shares of development assistance, early 2000s 
Disease category 
Communicable diseases, maternal 
health, perinatal conditions, and 
nutritional deficiencies 
Infectious diseases 
(excluding STDs and HIV/AIDS) 
STDs and HIV/AIDS 
Maternal health and perinatal 
conditions 
Nutritional deficiencies 
Noncommunicable diseases 
Injuries 
Total burden of disease 
DALYs 
lost, 
2001 
(OOOs) 
552,639 
327,407 
80,173 
115,494 
29,564 
678,842 
155,945 
1,387,426 
Share of 
total 
burden 
of disease 
39.8 
23.6 
5.8 
8.3 
2.1 
48.9 
11.2 
100.0 
Share of development 
assistance for health, AIDS, 
and population, 2003 
Directly 
attributable 
interventions 
plus imputed 
general 
Directly assistance 
attributable for health, 
inter- AIDS, and 
ventions population 
54.9 72.9 
10.2 20.8 
25.9 28.5 
16.0 19.8 
2 .8 3.8 
0.0 22.l 
0 .0 5.1 
54.9 100.0 
SOURCES: DALYs, Disease Control Priorities Project (see endnote 4); development assistance, Creditor Reporting System. 
spacing, "family planning" in the CRS. It is estimated to account for 8.3 
percent of the total burden of disease. 
-Nutritional deficiencies, which correspond to "basic nutrition" in the 
CRS database. These were estimated to account for 2.8 percent of the total 
burden of disease. 
Noncommunicable diseases are completely absent from the category 
of directly attributable interventions shown in Column 3 of Table 3, as are 
injuries, because interventions to address these areas are not perceived to 
be pro-poor. 5 Yet cardiovascular conditions, cancer, mental illness, diabe-
tes, and other noncommunicable conditions are accounting for a fast-rising 
share of mortality and morbidity in developing countries. This trend will 
become pronounced as populations age, as income levels rise, and as recent 
increases in tobacco use make their presence felt . 
Looking only at directly attributable interventions is misleading because 
general interventions ("policy administration and management," "basic health 
care," "basic health infrastructure," "medical education," etc.), amounting to 
45. l percent of all development assistance for health, AIDS, and population, 
also contribute to reducing the burden of disease. How to distribute general 
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health expenditure across disease categories is a contentious issue. Table 3 
follows one rule appealing in its simplicity, namely imputing general devel-
opment assistance for health, AIDS, and population across burden-of-disease 
categories using shares of the total burden of disease (Column 2). For ex-
ample, of the 45. l percent of such assistance that cannot be directly identi-
fied by disease intervention, I impute 5.8 percent to STDs including HIV I AIDS, 
8.3 percent to maternal and reproductive health, and so on. 
The most striking fact revealed by Table 3 is that HIV I AIDS is being 
allocated a much higher share of official development assistance than can 
be explained by its share in the burden of disease. STDs including HIV/AIDS 
accounted for 5.8 percent of the burden of disease in 2001, but for 25.9 
percent of assistance for health, AIDS, and population in 2003, or 28.5 per-
cent if my approach to imputation of general health assistance is accepted. 
Maternal and perinatal health, accounting for 8.3 percent of the burden of 
disease but for 16.0 percent of directly attributable assistance for health, 
population, and AIDS and 19.8 percent if general assistance is imputed, also 
received a share of resources higher than its share in the burden of disease. 
This is so despite the significant reduction in share during the 1990s that 
may be observed in Table 2. If only direct interventions are counted, infec-
tious diseases apart from HIV I AIDS received far less attention than would 
be warranted on the basis of their share in the burden of disease: 10.2 per-
cent of development assistance as opposed to 23.6 percent of the burden of 
disease. However, if general assistance is imputed, this anomaly is resolved, 
as infectious diseases excluding HIV I AIDS are estimated to account for 20.8 
percent of assistance for health, AIDS, and population, not far out of line 
with their share in the burden of disease. Noncommunicable diseases and 
injuries are estimated to receive far less assistance than would be justified 
by their contribution to the burden of disease. 
The data in Table 3 are plotted in Figure 1. The 45-degree line repre-
sents the locus along which each disease condition receives the same share 
of official development assistance as its share in the burden of disease. The 
discussion above has in effect compared the data points in Figure 1 with 
the 45-degree line. But we know, from Shiffman's work on infectious dis-
eases, that shares of development assistance are decided on the basis of fac-
tors in addition to the burden of disease. Therefore, it is unreasonable to 
expect the data points in Figure 1 to rest on the 45-degree line. For this 
reason, I also draw a least-squares trend line through the data points. Sta-
tistical inference, let alone hypothesis testing, is not possible with so few 
data points, but the trend line is still useful to give an idea of the average 
relationship between the burden of disease as expressed in disability-ad-
justed life years and development assistance. HIV I AIDS, in particular, and 
to lesser extent maternal and reproductive health, stand out as interven-
tion sectors that receive relatively generous allocations of assistance; nutri-
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FIGURE 1 Share of development assistance for health, AIDS, and 
population (including imputed general assistance for health, AIDS, and 
population) plotted against share of DALYs, early 2000s 
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tion and injuries appear as sectors that receive far less support than might 
be expected. 6 
It may be argued that the least-squares line in Figure 1 is essentially 
meaningless and so, therefore, is lying above or below it. In this case, we 
might look simply at development assistance per disability-adjusted life year. 
These data, shown in Table 4, reveal that whether or not general assistance 
is imputed, HIV/AIDS receives far more dollars per DALY than any other 
cause. Other infectious diseases, even when assigned a share of general as-
sistance commensurate with their large share of the burden of disease, re-
ceive a low level of assistance per DALY. By this criterion, the rising share 
of infectious diseases in development assistance discussed in the previous 
section appears to be well founded. 
The main conclusion here is that health priorities as revealed by pat-
terns of development assistance differ markedly from the priorities that might 
be predicted based on the burden of disease as measured in disability-ad-
justed life years. This conclusion broadens, to all disease categories, 
Shiffman's conclusion that infectious disease control priorities reflect many 
factors other than the burden of disease alone. 
HIV I AIDS receives an allocation of resources that is very generous com-
pared to its contribution to the total burden of disease. Yet this should not 
come as a surprise. HIV I AIDS advocacy groups have been very effective. 
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TABLE 4 Level of development assistance in 2003 per disability-adjusted 
life year (US$, 2002 prices) 
Infectious disease (ex cl. STDs and HIV I AIDS) 
STDs and HIV/AIDS 
Maternal and perinatal conditions 
Nutritional deficiencies 
Noncommunicable disease 
Injuries 
Development 
assistance per 
DALY (directly 
attributable inter-
ventions only) 
2.09 
21.88 
9.29 
6.30 
0.00 
0 .00 
Development 
assistance per 
DALY (including 
imputed general 
assistance for 
health, AIDS, 
and population) 
4.27 
24.06 
11.46 
8.45 
2.18 
2.17 
SOURCE: DALYs, Disease Control Priorities Project (see endnote 4); development assistance, Creditor Reporting 
System. 
The virus is spreading rapidly in many parts of the world, and current aid 
allocations may reflect the conviction that, if not addressed now, the epi-
demic will be even worse in the future. The fear factor, the concern in do-
nor countries that the epidemic may affect their own populations if not 
controlled elsewhere, cannot be ignored. In those countries that are most 
severely affected, governments are entirely unable to cope with the conse-
quences of the epidemic. If uncontrolled, the epidemic has the potential to 
undermine all health activities in some countries-indeed, all development 
(Roberts 2003: 80-81 ). Thu s, based largely on the availability of cost- effec-
tive means of HIV/AIDS prevention, the Copenhagen Consensu s of econo-
mists recently rated slowing the spread of HIV I AIDS as the highest-priority 
intervention for sustainable development (Lomborg 2004). 
The special status given to HIV I AIDS has been made explicit by the 
WHO Commission on Macroeconomics and Health, which in its Key Find-
ings termed the epidemic a "distinct and unparalleled catastrophe" requir-
ing "special consideration." This view has been bolstered by the joint World 
Bank-International Monetary Fund Development Committee (World Bank 
2003: 9-10), which in a survey of global public goods identified HIV/AIDS 
control as an area "especially" in need of attention and action. 
A word is in order on disease categories apart from HIV/ AIDS. Mater-
nal and reproductive health interventions are also attractive to donors for a 
number of reasons: they are typically highly cost-effective; maternal and 
reproductive health is of concern to a group widely perceived as vulnerable 
(women, children, and adolescents); and an effective global advocacy com-
munity is in place. Poor nutrition, however, also disproportionately affects 
children (and women), there are cost-effective interventions, and recent 
work suggests that poor nutrition is enormously important if attention is 
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given to its role as a co-factor in infectious disease prevention (Mason et al. 
2003) . Yet this category receives little support. 
Does development assistance for health and 
population reflect the priorities of poor countries? 
The institutional context 
The "Monterrey Consensus," which now forms the basis for all develop-
ment assistance, rests on three pillars: "country ownership," a comprehen-
sive and long-term approach, and partnership (World Bank 2003: 2) . The 
Monterrey Consensus provides the framework within which to pursue the 
Millennium Development Goals adopted by 189 states.7 Developed coun-
tries and the development agencies will, in return for poor countries' ef-
forts to attain the Millennium Development Goals, take primary responsi-
bility to establish a global partnership for development. 
The Millennium Development Goals emerged from widespread dissat-
isfaction with the effectiveness of aid and reflected insistence on a "results 
focus," especially improved monitoring and evaluation (Devaradjan et al. 
2002: 2). The cornerstone of the process for achieving the goals is the elabo-
ration, in all low-income countries, of a Poverty Reduction Strategy Paper 
(World Bank nd: 7 and 8; World Bank 2002: 5); this process, in turn, is 
meant to encourage countries to adopt a long-term vision that takes pov-
erty issues explicitly into account and reflects the views of all stakeholders. 
Poverty-reduction strategies are meant to be country-driven ("ownership" 
again), results-oriented, and par ticipatory, that is , reflect input of civil soci-
ety and the private sector (Christiansen and Hovland 2003: 3). Countries 
are meant to prioritize the Millennium Development Goals in accordance 
with their long-term vision of development needs. Donors, as evidenced by 
the March 2005 Paris Declaration on Aid Effectiveness, are committed to 
"aligning" their assistance with country priorities. 
Poor countries' health priorities and 
development assistance 
There is no clear-cut way to quantitatively measure government health pri-
orities in poor countries. However, the same lack of information is no longer 
a constraint when it comes to qualitative indicators of government health 
priorities. Systematic evidence on the role of health in countries' poverty-
reduction strategy papers is now available in a WHO database.8 This data-
base contains analytical findings on how health and poverty issues were 
dealt with in 36 poverty-reduction strategies drafted between 2000 and 2003. 
As described in detail elsewhere (MacKellar 2005), I summarized in-
formation available in the WHO database for three disease categories: in-
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fectious diseases excluding HIV I AIDS, HIV I AIDS, and maternal and repro-
ductive health. To roughly quantify the degree of government priority at-
tached to each area, I selected three criteria: 
-Is the disease category explicitly identified in the country's poverty-
reduction strategy? 
-Are proposed interventions targeted at the poor (or, in the case of 
HIV/AIDS, at vulnerable populations)? 
-Is the strategy explicitly linked to the relevant Millennium Devel-
opment Goals? 
If the answer to the question was "Yes," I assigned a score of I, if "No," 
a score of O; summing across the three criteria, I arrived at an index of dis-
ease-category prioritization that runs from 0 to 3. 
The logic behind the index is simple. Most countries, for instance, iden-
tified infectious disease as an area of concern, that is, most countries scored 
I on the first criterion. It stands to reason, however, that if a country truly 
ascribed a high priority to infectious disease control in its long-run devel-
opment strategy, it would take the subsequent steps of targeting proposed 
interventions toward the poor and linking its intervention strategy to the 
relevant Millennium Development Goals. 
Figures 2 to 7 are scatter plots of the share of three intervention 
subsectors in total official development assistance and in health, AIDS, and 
population assistance against the disease-category prioritization score. Noth-
ing in these charts shows evidence that recipient-country disease priorities 
as expressed in the poverty-reduction strategies strongly affect either how 
much of total development assistance is devoted to the corresponding in-
tervention subsector or how much of health, AIDS, and population assis-
tance is devoted to it. Countries that do not prioritize infectious disease are 
just as likely to have received a high share of total and health, AIDS, and 
population assistance dedicated to infectious disease control as countries 
prioritizing the disease category. A number of countries that assigned no 
priority to HIV I AIDS received, as is sensible, little assistance in that area. 
However, some countries that satisfied all three criteria in the area of HIV I 
AIDS received no more assistance in this area, proportionally speaking, than 
countries assigning less priority to the disease. The same observation holds 
for maternal and reproductive health. 
These negative results are open to three interpretations. The first, predi-
cated on the assumption that my disease-category prioritization scores ac-
curately measure country priorities, is that donors do not take these priori-
ties into account when allocating development assistance. 
The second interpretation is that the ad hoc index I have calculated is 
unsatisfactory, that is, the disease-category prioritization scores are mean-
ingless and their representation in Figures 2-7 is best ignored. 
A third interpretation is that the scores simply measure how well coun-
tries followed the guidelines for devising poverty-reduction strategies. In other 
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FIGURE 3 Infectious disease control 
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words, the degree to which a country explicitly targeted strategies toward 
the poor and linked proposed interventions to the relevant Millennium De-
velopment Goals may reflect not priorities per se, but whether the country 
was able to produce a strategy that conformed to international standards. 
In the third interpretation, donor countries seem to be more willing to 
allocate resources to general health policy, administration, and management, 
leaving it to recipient-country governments to make allocation decisions 
across disease categories. After all, the move from project-based approaches 
to sector-wide support is a vital aspect of country "ownership," and the main 
constraint to ownership is generally held to be country capacity. In Figures 
8 and 9, I plot general health policy, administration, and management sup-
port against the average of the infectious disease, HIV I AIDS, and maternal 
and reproductive health prioritization scores described above. My hypoth-
esis is that the average prioritization score serves as a proxy for country 
capacity. There is some evidence in favor of this interpretation: most coun-
tries receiving a high share of development assistance in the form of gen-
eral support scored at least 2 on the average index. The evidence is hardly 
compelling, however; some countries that scored high received relatively 
small amounts of general health-sector assistance; some that scored low re-
ceived relatively large amounts. 
The evidence presented in this section is ambiguous. This in itself is cause 
for concern: however imperfect the index, one would expect to see at least 
some evidence of a relationship between the way a disease category is treated 
in the country strategy and the allocation of development assistance. It ap-
pears that a hypothetical advisor preparing for a country mission or a new 
program officer in an international development organization would not be 
able to infer with any confidence, from a reading of a country's poverty-re-
duction strategy, how development assistance for health was being allocated. 
FIGURE 8 Health policy and 
administration as share of total 
development assistance 
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This suggests room for improvement in the process of preparing poverty-re-
duction strategies, in the allocation of official development assistance, or both. 
Conclusions 
The gap between needs and resources in global health development is enor-
mous, and, as a result, so is the importance of priority setting. Three ques-
tions of relevance to policymakers as they address this challenge are: What 
are the recent trends in development assistance for the health sector, and 
what do they tell us about overall priorities in health? What factors explain 
priorities within the health sector? And how closely do observed develop-
ment assistance priorities correspond to the health priorities expressed by 
policymakers in poor countries? In this article I have presented findings 
related to these questions. 
The short answer to the first question is that HIV I AIDS is the priority. 
It accounts for the increased share of health in total official development 
assistance over the last decade. If HIV/AIDS is excluded from the calcula-
tion, health has actually declined as a share of development assistance, from 
5.4 percent in 1993 to 5.0 percent in 2003. Within the health, AIDS, and 
population sector, apart from HIV/AIDS only infectious disease control has 
seen an increased share of resources. It is possible that the rising share of 
infectious disease control, a classic public good, reflects growing reliance on 
the global public good rationale for international assistance, but other ex-
planations cannot be excluded. Basic health care and infrastructure, health 
education and personnel development, reproductive health and family plan-
ning, and basic nutrition-all pro-poor interventions-have experienced 
declining shares. Taken together, pro-poor health interventions apart from 
HIV I AIDS have seen their share of health assistance drop from 57 .2 per-
cent to 42.0 percent and their share of total development assistance resources 
drop from 3.1 percent to 2.8 percent. These trends apply not only to aid-
recipient countries as a whole, but to the subset of least-income countries. 
The observed declines in share are consistent neither with the current 
emphasis on health as a priority sector in development, as evidenced by the 
prominence of health concerns in the Millennium Development Goals, nor 
with growing awareness of links between health and poverty. The declines 
lend strength to concerns, voiced by groups such as the WHO Commission 
on Macroeconomics and Health, regarding the insufficiency of international 
support for health. They also raise issues about how effectively health assis-
tance is addressing the needs of the poor. Finally, concentrating assistance 
on HIV I AIDS, however laudable the intent, carries with it the danger of 
lopsided, distorted health-sector development. 
The answer to the second question is that the most commonly cited 
prioritization tool, the burden of disease as measured in disability-adjusted 
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life years, is insufficient to explain observed priorities. Previous research on 
infectious diseases has concluded that factors apart from the burden of dis-
ease play a role in determining how development assistance is allocated. 
Such factors, it has been argued, include the existence of cost-effective in-
terventions, the characteristics of the victims, the presence of a global ad-
vocacy community, the inability of countries to cope on their own, and the 
possibility of catastrophic national and international consequences if reme-
dial steps are not taken. I have extended and strengthened these assertions 
by concluding that they apply to all disease categories, not just infectious 
diseases. HIV I AIDS stands out for the large allocation of resources it re-
ceives relative to its contribution to the total burden of disease; so too, though 
less dramatically, does reproductive and maternal health. Disease catego-
ries receiving less support than might be expected on the basis of their con-
tribution to the burden of disease are injuries and nutritional disorders. 
These results suggest the need for efforts to devise explicit priority-
setting frameworks in which the burden of disease is only one factor among 
many. Ongoing work by the Global Forum for Health Research (2004) pro-
vides a model for such approaches, although this work is limited to priority 
setting in health research and development. 
In making a first systematic attempt to compare aid allocations to low-
income countries' health priorities as expressed in their poverty-reduction 
strategies, I have arrived at an ambiguous answer to the third question, 
namely, if development assistance allocations and country priorities do cor-
respond, the correspondence is not plainly evident. I detected no clear rela-
tionship between priorities expressed in poverty-reduction strategies and 
the composition of development assistance. Methodological problems may 
be to blame-for example, the index I have devised may not measure pri-
orities per se but rather how well these priorities have been translated into 
the framework of poverty-reduction strategies. In this case, however, I would 
expect the index to be related to the share of development assistance allo-
cated to general health policy, administration, and management. I found 
only slim evidence of this relationship. Whatever the explanation, I con-
clude that the absence of a clear relationship between how health is treated 
in the preparation of poverty-reduction strategies and the composition of 
development assistance should signal to policymakers that there is room 
for improvement in the process of preparing such strategies, in the alloca-
tion of development assistance, or both. 
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Notes 
The research resulting in this article was sup-
ported by the Development Centre of the Or-
ganization for Economic Co-operation and 
Development; however, the opinions ex-
pressed are entirely those of the author. Use-
ful comments by Helmut Reisen and Ulrich 
Heimenz of the Centre are gratefully acknowl-
edged. 
l For example, following a $750 million 
start-up grant from the Bill and Melinda Gates 
Foundation, the Global Alliance for Vaccines 
and Immunization has raised $577 million in 
bilateral donor support but only $5 million in 
private non-philanthropy-sector grants (Glo-
bal Alliance for Vaccines and Immunization 
2005). Out of $35.4 million disbursed by Roll 
Back Malaria in 2002, $25.7 million was fi-
nanced by traditional donors and $8.7 million 
by WHO (Roll Back Malaria 2003). Out of 
$340 million raised by the International AIDS 
Vaccine Initiative through the end of 2003, vir-
tually all apart from a $ 100 million start-up 
grant from the Gates Foundation came from 
bilateral donors and multilateral institutions 
(Skolnick et al. 2003). Out of $5, 706 million 
pledged through 2008 to the Global Fund to 
Fight AIDS, Tuberculosis, and Malaria , only 
$154 million comes from foundations (again, 
mostly the Gates Foundation), private firms, 
and individuals (the Global Fund to Fight 
AIDS, Tuberculosis, and Malaria 2004). In 
short, these new actors are simply replicating 
the existing structure of aid flows . 
2 These are the country- and project-level 
data in the "All details# (5-digit category) da-
tabase. Available online at «http://wwwl.oecd. 
org/scripts/cde/members/CRSAuthenticate. 
asp». 
3 If one took account of the fact that many 
reproductive health and family planning 
projects contain HIV/AIDS components, the 
decline in share would be more pronounced. 
4 Comprehensive global estimates of dis-
ability-adjusted life years by disease category 
were first prepared by the WHO Global Bur-
den of Disease Project as background research 
for the 1993 World Development Report (Murray 
and Lopez 1996). DALYs were proposed, and 
have been broadly accepted, as one of the most 
important tools for health policy priority set-
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ting (World Bank forthcoming 2006). In re-
cent years, WHO produced updated burden-
of-disease estimates for 2000, 2001, and 2002 
(Mathers et al. 2002). A minor inconvenience 
is that the regions used by WHO for aggregat-
ing country-level DALY estimates are not com-
parable to the regions used by the Develop-
ment Assistance Committee. However, the 
WHO estimates for 2001 have been re-aggre-
gated according to World Bank income regions 
(which are comparable to Development Assis-
tance Committee regions) by the Disease Con-
trol Priorities Project alluded to above. These 
estimates, to be published next year in the sec-
ond edition of Disease Control Priorities in Devel-
oping Countries (World Bank forthcoming 
2006), provide the basis for the discussion in 
this section. The data have been posted online 
(with accompanying methodological informa-
tion) at «http://www.fic.nih.gov/dcpp/gbd. 
html». 
5 A detailed search of project titles, as op-
posed to 5-digit CRS codes, would turn up a 
handful of projects in these areas; however, 
for practical purposes, we may assume that de-
velopment assistance directly targeted at non-
communicable diseases and injuries was zero 
or close to it. 
6 The slope of the trend line in Figure l is 
admittedly sensitive to whether my imputa-
tion assumption is accurate, especially as it ap-
plies to noncommunicable diseases. If devel -
opment assistance for general health is 
disproportionately benefiting the well-to-do 
through public health systems insufficiently 
attuned to the needs of the poor (an argument 
made by many), then the trend line might be 
steeper. This is because the rich live longer and 
are more likely to suffer from chronic and de-
generative conditions; hence, the data point 
corresponding to noncommunicable diseases 
would shift vertically upward. However, real-
locating general health assistance to noncom-
municable diseases would mean reallocating 
it from other disease conditions. It is likely that 
HIV I AIDS, which places heavy demands on 
hospital systems, would still be an outlier on 
the high side of the new trend line. It is diffi-
cult to make similar speculations about other 
disease conditions. 
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7 The targets associated with the health-
related Millennium Development Goals are to 
(i) reduce child mortality by two-thirds be-
tween 1990 and 2015, (ii) reduce the mater-
nal mortality ratio by three-quarters between 
1990 and 2015, (iii) halt and begin to reverse 
the spread of AIDS by 2015, (iv) halt and be-
gin to reverse the incidence of malaria and 
other major diseases by 2015. In the area of 
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